A NORML Reminder: Beware of COVID-19 Cure All Claims
NORML
MARCH 23, 2020
For example, one recent CBD provider recently received warning letters from the US Food and Drug Administration and the Federal Trade Commission for improperly marketing the agent as a key component of its COVID-19 prevention package.
Let's personalize your content